Roberto F. Caporali

Branch Of Medical Statistics
Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 412 publications

TNF inhibitors for the long-term management of juvenile idiopathic arthritis associated uveitis: real-life data from the ITHACA cohort.

TNF inhibitors for the long-term management of juvenile idiopathic arthritis associated uveitis: real-life data from the ITHACA cohort.

Journal: Expert opinion on biological therapy

Published: June 28, 2026

A rheumatological reading of GLP-1 receptor agonists: from muscle loss to musculoskeletal gain.

A rheumatological reading of GLP-1 receptor agonists: from muscle loss to musculoskeletal gain.

Journal: International journal of obesity (2005)

Published: June 22, 2026

Comment on: Exploring the effects of GLP-1 receptor agonists in fibromyalgia: a propensity-matched real-world cohort using the TriNetX research platform.

Comment on: Exploring the effects of GLP-1 receptor agonists in fibromyalgia: a propensity-matched real-world cohort using the TriNetX research platform.

Journal: Rheumatology (Oxford, England)

Published: May 05, 2026

Could Incretin-Based Weight Loss Unmask a Modifiable Nociplastic Pain Phenotype? A Rheumatological Reading of SURMOUNT-5.

Could Incretin-Based Weight Loss Unmask a Modifiable Nociplastic Pain Phenotype? A Rheumatological Reading of SURMOUNT-5.

Journal: Diabetes, obesity & metabolism

Published: May 01, 2026

Filgotinib in Moderate to Severe Rheumatoid Arthritis in a Real-World Setting: Up to 6-Month Effectiveness, Patient-Reported Outcomes, and Persistence, and up to 24-Month Safety from More than 1400 Patients in the FILOSOPHY and PARROTFISH Studies.

Filgotinib in Moderate to Severe Rheumatoid Arthritis in a Real-World Setting: Up to 6-Month Effectiveness, Patient-Reported Outcomes, and Persistence, and up to 24-Month Safety from More than 1400 Patients in the FILOSOPHY and PARROTFISH Studies.

Journal: Rheumatology and therapy

Published: April 29, 2026

Anifrolumab for rituximab-induced SCLE and cryoglobulinemic vasculitis in primary Sjögren's disease: a case report.

Anifrolumab for rituximab-induced SCLE and cryoglobulinemic vasculitis in primary Sjögren's disease: a case report.

Journal: Frontiers in pharmacology

Published: April 14, 2026

Selexipag in systemic sclerosis-associated pulmonary arterial hypertension: long-term real-world data from a multicentre Italian cohort.

Selexipag in systemic sclerosis-associated pulmonary arterial hypertension: long-term real-world data from a multicentre Italian cohort.

Journal: Rheumatology (Oxford, England)

Published: March 21, 2026

Revisiting osteoarthritis as an inflammatory disease: characterization of synovitis grading and synovial pathotypes in surgical specimens.

Revisiting osteoarthritis as an inflammatory disease: characterization of synovitis grading and synovial pathotypes in surgical specimens.

Journal: Arthritis research & therapy

Published: March 02, 2026

Interstitial lung disease in ANCA-associated vasculitis: comment on the article by Chalkia et al.

Interstitial lung disease in ANCA-associated vasculitis: comment on the article by Chalkia et al.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: February 27, 2026

Real-world experience with personalised belimumab spacing in sustained SLE remission: a multicentre study.

Real-world experience with personalised belimumab spacing in sustained SLE remission: a multicentre study.

Journal: Lupus science & medicine

Published: February 18, 2026

Evaluating machine learning tools to assist title and abstract screening in systematic literature reviews: a report based on the EULAR RA Management Recommendations Task Force.

Evaluating machine learning tools to assist title and abstract screening in systematic literature reviews: a report based on the EULAR RA Management Recommendations Task Force.

Journal: Annals of the rheumatic diseases

Published: February 16, 2026

Tocilizumab and Rituximab in Systemic Sclerosis: A Real-Life Retrospective Observational Study Across Different Clinical Phenotypes.

Tocilizumab and Rituximab in Systemic Sclerosis: A Real-Life Retrospective Observational Study Across Different Clinical Phenotypes.

Journal: Journal of personalized medicine

Published: February 16, 2026

Showing 1-12 of 412

Last Updated: 09/26/2026